Modeling medulloblastoma in vivo and with human cerebellar organoids
Group 3 medulloblastoma (MB) is considered one of the most aggressive forms of this cancer. Here, the authors show that Otx2 and c-MYC oncogenes can drive Group 3 MB formation in mouse and human cerebellar organoids while SMARCA4 overexpression or a EZH2-specific inhibitor can inhibit tumorigenesis.
Enregistré dans:
Auteurs principaux: | Claudio Ballabio, Marica Anderle, Matteo Gianesello, Chiara Lago, Evelina Miele, Marina Cardano, Giuseppe Aiello, Silvano Piazza, Davide Caron, Francesca Gianno, Andrea Ciolfi, Lucia Pedace, Angela Mastronuzzi, Marco Tartaglia, Franco Locatelli, Elisabetta Ferretti, Felice Giangaspero, Luca Tiberi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9519a8f838f84cd89a2a82dbc13a35e4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cerebellar Liponeurocytoma Mimicking Medulloblastoma: Case Report of a Childhood and Literature Review
par: Changhui Dong, et autres
Publié: (2021) -
Cytotoxic effects and tolerability of gemcitabine and axitinib in a xenograft model for c-myc amplified medulloblastoma
par: Stefanie Schwinn, et autres
Publié: (2021) -
The transcriptional landscape of Shh medulloblastoma
par: Patryk Skowron, et autres
Publié: (2021) -
Wnt activation as a therapeutic strategy in medulloblastoma
par: Branavan Manoranjan, et autres
Publié: (2020) -
CREB signaling activity correlates with differentiation and survival in medulloblastoma
par: Inna Armandari, et autres
Publié: (2021)